APA (7th ed.) Citation

I, M., Z, B., F, K., J, H., A, K., SN, M., . . . Z, S. (2025). Design, synthesis, in vitro, and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents. RSC advances, 15(2), 948. https://doi.org/10.1039/d4ra07650h

Chicago Style (17th ed.) Citation

I, Munir, et al. "Design, Synthesis, in Vitro, and in Silico Studies of Novel Isatin-hybrid Hydrazones as Potential Triple-negative Breast Cancer Agents." RSC Advances 15, no. 2 (2025): 948. https://doi.org/10.1039/d4ra07650h.

MLA (9th ed.) Citation

I, Munir, et al. "Design, Synthesis, in Vitro, and in Silico Studies of Novel Isatin-hybrid Hydrazones as Potential Triple-negative Breast Cancer Agents." RSC Advances, vol. 15, no. 2, 2025, p. 948, https://doi.org/10.1039/d4ra07650h.